Although KRAS is a proto-oncogene associated principally with cancer (Zhu et al. 2008), at the transcriptional level it acts as a short-term inductor to astrocytes in response to stimulus and as a sensor that adapts cells to metabolic needs and oxidative stress in the brain (Messina et al. 2017). Here, KRAS is linked to cancer.